Join us in-person in Chicago this September!
Master the Skills Needed to Overcome the Challenges of Modern Paragraph IV Litigation
Each fall, leading pharmaceutical patent litigators for brand name and generic drug companies gather at the Paragraph IV Disputes Master Symposium in Chicago to receive up-to-the-minute information on the latest developments affecting Hatch-Waxman litigation and participate in significant peer-to-peer networking opportunities.
As the industry prepares to address the fallout of global pharmaceutical patent losses of billions of dollars and the impact of evolving law, regulation and policy impacting the Hatch-Waxman landscape, the time for this conference has never been more relevant.
2022 Co-Chairs
Linda Friedlieb
Division Counsel
AbbVie
“We can’t wait to gather in Chicago to discuss the key issues at the cutting edge of Hatch-Waxman litigation. The PIV conference attracts broad participation from key in-house and outside counsel, as well as the Patent Office and judges. It’s an excellent opportunity to cross-pollinate ideas and strategies.”
Ryan Daniel
Chief Patent Counsel
Fresenius Kabi USA
“We’re excited to participate in ACI’s 8th Annual Paragraph IV Master Symposium, here in Chicago and in person for the first time in three years. It’s a very welcome opportunity to connect and engage with colleagues and the judiciary regarding the evolving landscape of Hatch-Waxman law and the pharmaceutical industry.”
2022 Members of the Federal Judiciary
Hon. Colm F. Connolly
Chief Judge
United States District Court, District of Delaware
Hon. Stanley R. Chesler
District Judge
United States District Court, District of New Jersey
Hon. Joshua Wolson
District Judge
United States District Court, Eastern District of Pennsylvania
(Visiting Judge, District of Delaware)
Hon. Douglas E. Arpert
Magistrate Judge
United States District Court, District of New Jersey
Hon. Christopher J. Burke
Magistrate Judge
United States District Court, District of Delaware
WHO YOU WILL MEET
Patent attorneys and litigators (in-house & law firms) who represent:
- Brand name pharmaceutical companies
- Generic pharmaceutical companies
- Biopharmaceutical companies
Related Conferences
